Journal of Exotic Pet Medicine
Volume 15, Issue 4 , Pages 281-283 , October 2006

Meloxicam

  • Megan S. Kirchgessner, DVM

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Megan S. Kirchgessner, DVM, Zoological Intern, Louisiana State University, School of Veterinary Medicine, Department of Veterinary Clinical Sciences, Baton Rouge, LA 70803.

References 

  1. Curry S, Cogar S, Cook J. Nonsteroidal antiinflammatory drugs: a review. J Am Anim Hosp Assoc. 2005;41:298–309
  2. In:  Adams H editors. Veterinary Pharmacology and Therapeutics. ed 8.. Ames, Iowa: Iowa State University; 2001;
  3. Bertolini A, Ottani A, Sandrini A. Dual acting anti-inflammatory drugs: a reappraisal. Pharmacol Res. 2001;44:437–450
  4. Vane J, Bakhle Y, Botting R. Cyclooxygenase 1 and 2. Ann Rev Pharmacol Toxicol. 1998;38:97–120
  5. Robinson D. Eicosanoids, inflammation, and antiinflammatory drugs. Clin Exp Rheum. 1989;7:155–161
  6. Plumb D. Meloxicam. In:  Plumb DC editors. Veterinary Drug Handbook. ed 4. Ames, IA: Iowa State Press; 2002;p. 490–491
  7. Wallace J. Pharm profile: meloxicam. Compend Contin Educ Pract Vet. 2003;15:64–65
  8. Slingsby L. Waterman-Pearson: Comparison between meloxicam and carprofen for postoperative analgesia after feline ovariohysterectomy. J Sm Anim Pract. 2002;43:286–289
  9. Toutain P, Reymond N, Laroute V, et al. Pharmacokinetics of meloxicam in plasma and urine of horses. Am J Vet Res. 2004;65:1542–1547
  10. Priester W, McKay F. The occurrence of tumors in domestic animals. J Natl Cancer Inst Monogr. 1980;54:1–210
  11. Farrow D, Vaughan T, Hansten P, et al. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidem. 1998;7:97–102
  12. Tsujii M, Kawano S, DuBois R. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA. 1997;94:3336–3340
  13. Tsujii M, Kawano S, Tsuji S, et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998;93:705–719
  14. Wolfesberger B, Walter I, Hoelzl C, et al. Antineoplastic effect of the cyclooxygenase inhibitor meloxicam on canine osteosarcoma cells. Res Vet Sci. 2005;80:308–316
  15. APHIS. Treatment of respiratory disease in US feedlots (Info sheet on veterinary services). Fort Collins: United States Department of Agriculture; 2001;
  16. Ramierz-Romero R, Brogden K. The potential role of the Arthus and Shwartzman reactions in the pathogenesis of pneumonic pasturellosis. Inflamm Res. 2000;49:98–101
  17. Friton G, Cajal C, Ramirez-Romero R. Long-term effects of meloxicam in the treatment of respiratory diseases in fattening cattle. Vet Rec. 2005;156:809–811
  18. Crandell D, Mathews K, Dyson D. Effect of meloxicam and carprofen on renal function when administered to healthy dogs prior to anesthesia and painful stimulation. Am J Vet Res. 2004;65:1384–1390
  19. Fresno L, Moll J, Penalba B, et al. Effects of preoperative administration of meloxicam on whole blood platelet aggregation, buccal mucosal bleeding time, and haematolgoical indices in dogs undergoing elective ovariohysterectomy. Vet J. 2005;170:138–140
  20. Pereira M, Werther K. Comparative evaluation of the renal effects of a seven-day therapy with flunixin meglumine, ketoprofen and meloxicam in budgerigar (Melopsittacus undutatus). Proc Annu Conf AAZV, AAWV, WDA. 2004;610–612
  21. Laudanno O, Cesolari J, Esnarriaga M, et al. In vivo selectivity of nonsteroidal antiinflammatory drugs and gastrointestinal ulcers in rats. Dig Dis Sci. 2000;45:1359–1365
  22. Wilson G, Hernandez-Divers S, Budsber S, et al. Pharmacokinetics and use of meloxicam in psittacine birds. Proc Annu Conf Assoc Avi Vet. 2004;7–9
  23. Lees P, Sedgewick A, Higgins A, et al. Pharmacodynamics and pharmacokinetics of meloxicam in the horse. Br Vet J. 1991;147:97–108
  24. Schmid J, Busch U, Heinzel G, et al. Pharmacokinetics and metabolic pattern of meloxicam after intravenous infusion and oral administration to healthy subjects. Drug Metab Dispos. 1995;23:1206–1213
  25. Baert K, Nackaerts J, De Backer P. Disposition of sodium salicylate, flunixin, and meloxicam after intravenous administration in ostriches (Struthio camelus). J Av Med Surg. 2002;16:123–128
  26. Baert K, De Backer P. Comparative pharmacokinetics of three non-steroidal anti-inflammatory drugs in five bird species. Comp Biochem Physiol. 2003;134:25–33
  27. Turner P, Chen H, Taylor W. Pharmacokinetics of meloxicam in rabbits after single and repeat oral dosing. Comp Med. 2006;56:63–67
  28. Busch U, Schmid J, Heinzel G, et al. Pharmacokinetics of meloxicam in animals and the relevance to humans. Drug Metab Disp. 1998;26:576–584
  29. Hernandez-Divers S. Single-dose oral and intravenous pharmacokinetics of meloxicam in the green iguana (Iguana iguana). Proc Annu Conf ARAV. 2004;106–107

PII: S1557-5063(06)00148-0

doi: 10.1053/j.jepm.2006.09.009

Journal of Exotic Pet Medicine
Volume 15, Issue 4 , Pages 281-283 , October 2006

Article Tools